Clinical Trial Information Request for Protocol 24-727 Title A phase 2 study of elranatamab in combination with isatuximab (ELISA) in relapsed and refractory multiple myeloma PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone